ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ralph J. Damiano, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jayawant, A. M.
Right arrow Articles by Damiano, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jayawant, A. M.
Right arrow Articles by Damiano, R. J., Jr

Ann Thorac Surg 1999;67:618-623
© 1999 The Society of Thoracic Surgeons


Original Articles

2,3-Butanedione monoxime cardioplegia: advantages over hyperkalemia in blood-perfused isolated hearts

A. Mark Jayawant, MDa, Edward R. Stephenson, Jr, MDa, Ralph J. Damiano, Jr, MDa

a Milton S. Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania, USA

Accepted for publication July 23, 1998.

Address reprint requests to Dr Damiano, Section of Cardiovascular Surgery, Milton S. Hershey Medical Center, Pennsylvania State-Geisinger Health System, PO Box 850, Hershey, PA 17033
e-mail: rdamiano{at}psghs.edu

Background. 2,3-Butanedione monoxime (BDM) has been shown to possess cardioprotective properties related to the inhibition of cross-bridge force development, the reduction of myofilament Ca2+ sensitivity, and the attenuation of intracellular Ca2+ transients. This study tested the hypothesis that cardiac arrest achieved with BDM would be as effective as that achieved with St. Thomas’ solution (StT).

Methods. Isolated rabbit hearts, studied on a blood-perfused Langendorff column, underwent 1 hour of ischemia (37°C) and 30 minutes of reperfusion. Cardioplegia was administered every 20 minutes in the form of (1) Krebs-Henseleit solution only (control), (2) 20 mmol/L of BDM, or (3) StT. Recovery of developed pressure, atrioventricular activation times, and tissue water content were measured.

Results. Recovery of developed pressure for the control, BDM, and StT groups was 44% ± 3% (p < 0.05 versus BDM and StT), 57% ± 5%, and 62% ± 4%, respectively. Atrioventricular activation times were significantly prolonged in the control group (42 ± 15 ms, p = 0.042) and the StT group (26 ± 9 ms, p = 0.034), but not in the BDM group (14 ± 8 ms). Tissue water content after reperfusion was 80% ± 0.4%, 80% ± 0.2%, and 76% ± 1.0% (p < 0.05 versus control) in the control, StT, and BDM groups, respectively.

Conclusions. 2,3-Butanedione monoxime was as effective as StT in protecting the myocardium. Unlike StT, BDM ameliorated myocardial edema and atrioventricular conduction delay after reperfusion.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. Borlak and C. Zwadlo
The Myosin ATPase Inhibitor 2,3-Butanedione monoxime Dictates Transcriptional Activation of Ion Channels and Ca2+-Handling Proteins
Mol. Pharmacol., September 1, 2004; 66(3): 708 - 717.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Mukherjee, W. M. Yarbrough, E. S. Reese, J. S. Leiser, J. A. Sample, J. T. Mingoia, A. E. Hardin, R. E. Stroud, J. E. McLean, J. W. Hendrick, et al.
Myocyte contractility with caspase inhibition and simulated hyperkalemic cardioplegic arrest
Ann. Thorac. Surg., May 1, 2004; 77(5): 1684 - 1689.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. A. F. Tulner, R. J. M. Klautz, G. L. van Rijk-Zwikker, F. H. M. Engbers, J. J. Bax, J. Baan, E. E. van der Wall, R. A. Dion, and P. Steendijk
Perioperative Assessment of Left Ventricular Function by Pressure-Volume Loops Using the Conductance Catheter Method
Anesth. Analg., October 1, 2003; 97(4): 950 - 957.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. J. Chambers
Mechanisms and alternative methods of achieving cardiac arrest
Ann. Thorac. Surg., February 1, 2003; 75(2): S661 - 666.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
U. Mehlhorn, H. J. Geissler, G. A. Laine, and S. J. Allen
Myocardial fluid balance
Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1220 - 1230.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.